241 related articles for article (PubMed ID: 37449925)
1. Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
El-Mallawany NK; Alexander S; Fluchel M; Hayashi RJ; Lowe EJ; Giulino-Roth L; Wistinghausen B; Hermiston M; Allen CE;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30565. PubMed ID: 37449925
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
3. Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.
Bollard CM; Lim MS; Gross TG;
Pediatr Blood Cancer; 2013 Jun; 60(6):979-84. PubMed ID: 23255391
[TBL] [Abstract][Full Text] [Related]
4. NHL in adolescents and young adults: A unique population.
Hochberg J; Flower A; Brugieres L; Cairo MS
Pediatr Blood Cancer; 2018 Aug; 65(8):e27073. PubMed ID: 29741220
[TBL] [Abstract][Full Text] [Related]
5. Pediatric lymphomas and histiocytic disorders of childhood.
Allen CE; Kelly KM; Bollard CM
Pediatr Clin North Am; 2015 Feb; 62(1):139-65. PubMed ID: 25435117
[TBL] [Abstract][Full Text] [Related]
6. Mature B-cell lymphomas in adolescents and young adults.
El-Mallawany NK; Giulino-Roth L; Burke JM; Hermiston M; Allen CE
EJHaem; 2023 Nov; 4(4):912-920. PubMed ID: 38024628
[TBL] [Abstract][Full Text] [Related]
7. Advances in therapies for non-Hodgkin lymphoma in children.
Kobos R; Terry W
Hematology Am Soc Hematol Educ Program; 2015; 2015():522-8. PubMed ID: 26637768
[TBL] [Abstract][Full Text] [Related]
8. Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1.
O'Suoji C; Welch JJ; Perkins SL; Smith LM; Weitzman S; Simko SJ; Galardy PJ; Bollard CM; Gross TG; Termuhlen AM
Pediatr Blood Cancer; 2016 May; 63(5):794-800. PubMed ID: 26728447
[TBL] [Abstract][Full Text] [Related]
9. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
[TBL] [Abstract][Full Text] [Related]
10. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
12. Pediatric non-Hodgkin's lymphoma.
Gross TG; Termuhlen AM
Curr Oncol Rep; 2007 Nov; 9(6):459-65. PubMed ID: 17991353
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.
Majhail NS; Bajorunaite R; Lazarus HM; Wang Z; Klein JP; Zhang MJ; Rizzo JD
Br J Haematol; 2009 Oct; 147(1):129-39. PubMed ID: 19573079
[TBL] [Abstract][Full Text] [Related]
14. Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
Castellino SM; Giulino-Roth L; Harker-Murray P; Kahn JM; Forlenza C; Cho S; Hoppe B; Parsons SK; Kelly KM;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30580. PubMed ID: 37505794
[TBL] [Abstract][Full Text] [Related]
15. Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study.
Pallotti F; Pelloni M; Faja F; Di Chiano S; Di Rocco A; Lenzi A; Lombardo F; Paoli D
Hum Reprod; 2021 Jan; 36(1):16-25. PubMed ID: 33257989
[TBL] [Abstract][Full Text] [Related]
16. Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
Rosolen A; Perkins SL; Pinkerton CR; Guillerman RP; Sandlund JT; Patte C; Reiter A; Cairo MS
J Clin Oncol; 2015 Jun; 33(18):2112-8. PubMed ID: 25940716
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients.
Naik S; Martinez CA; Omer B; Sasa G; Yassine K; Allen CE; Kamdar K; Orth R; Wu M; Leung K; Gottschalk S; Brenner MK; Heslop HE; Krance RA
Blood Adv; 2019 Sep; 3(18):2689-2695. PubMed ID: 31511228
[TBL] [Abstract][Full Text] [Related]
18. Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future.
Cairo MS; Raetz E; Lim MS; Davenport V; Perkins SL
Pediatr Blood Cancer; 2005 Nov; 45(6):753-69. PubMed ID: 15929129
[TBL] [Abstract][Full Text] [Related]
19. Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma.
Cassaday RD; Press OW; Pagel JM; Rajendran JG; Gooley TA; Fisher DR; Holmberg LA; Miyaoka RS; Sandmaier BM; Green DJ; Gopal AK
Clin Cancer Res; 2019 Dec; 25(23):6932-6938. PubMed ID: 31481510
[TBL] [Abstract][Full Text] [Related]
20. Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children's Oncology Group study A5962.
Harris RE; Termuhlen AM; Smith LM; Lynch J; Henry MM; Perkins SL; Gross TG; Warkentin P; Vlachos A; Harrison L; Cairo MS
Biol Blood Marrow Transplant; 2011 Feb; 17(2):249-58. PubMed ID: 20637881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
